雅克2V617F可逆激活显示其在骨髓增殖新生体中的基本要求
Andrew J Dunbar1,2,3, Robert L Bowman1, Young C Park1
1Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer discovery
|January 17, 2024
概括
针对骨髓增殖性瘤 (MPNs) 中的JAK2V617F突变提供了比目前的JAK抑制剂更大的治疗潜力. 在小鼠中禁用这种突变消除了MPN特征和枯竭的疾病驱动干细胞,改善了生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在JAK/STAT信号传导中的功能获取突变,特别是JAK2V617F,在骨髓增殖性瘤 (MPNs) 中很普遍.
- 目前的JAK抑制剂提供了症状缓解,但无法消除突变细胞或诱导MPNs的缓解.
研究的目的:
- 调查在MPN中专门废除突变JAK2信号的治疗潜力.
- 开发和使用一种新的小鼠模型来评估Jak2V617F无活化的体内效应.
主要方法:
- 使用双重重组合酶系统 (Dre-rox/Cre-lox) 开发一种具有内源Jak2V617F的条件诱导性小鼠模型.
- 序列激活和非激活Jak2V617F以研究其致癌作用和治疗向.
主要成果:
- 在小鼠模型中Jak2V617F的非激活取消了MPN特征,并耗尽了突变造血干细胞和原始细胞.
- 完全删除Jak2V617F导致整体存活率显著改善,超过了药理学JAK抑制的结果.
- 该模型甚至在存在并发的Tet2损失的情况下也证明了有效性.
结论:
- 在MPN中,JAK2V617F突变是关键的治疗标.
- 与当前的JAK抑制剂相比,直接针对JAK2V617F提供了更高的疗效.
- 双重组合酶系统是研究突变特异性瘤性依赖的宝贵工具.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


